How much experience do we have with biosimilar medicines?

Biosimilar medicines have been used since 2006, with Europe being the first region to approve them. Their use has steadily increased over time and they are currently available in more than 60 countries around the world. Biosimilar medicines have been available in Australia since 2010, where they’ve helped improve the lives of thousands of Australians with serious diseases such as cancer, rheumatoid arthritis, inflammatory bowel disease, severe psoriasis, multiple sclerosis and kidney disease.